Giulio Francolini
24PUBLICATIONS
42CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (24)
Sort by Publication Date:
|Apr 10, 2026
Androgen receptor pathway inhibitor intensification in non-metastatic hormone-sensitive prostate cancer: current evidence and clinical implications.Patricia Willisch, Beatriz Vázquez-Barreiro, Ana Plata
|Dec 15, 2025
Impact of BRCA in patients undergoing abiraterone ± stereotactic body radiotherapy: the ARTO trial.Giulio Francolini, Vanessa Di Cataldo, Pietro Garlatti
|Jul 12, 2025
Stereotactic Salvage Radiotherapy for Macroscopic Prostate Bed Recurrence After Prostatectomy: STARR (NCT05455736): An Early Analysis from the STARR Trial.Niccolo' Bertini, Giulio Francolini, Vanessa Di Cataldo
|May 21, 2025
Current diagnostic and therapeutic options in de novo low-volume metastatic hormone-sensitive prostate cancer.Gianluca Ingrosso, Andrea Lancia, Lilia Bardoscia
|Mar 18, 2025
Hypofractionated radiotherapy in elderly patients (≥75 years) affected by localized prostate cancer: a multicenter retrospective analysis from the IPOPROMISE study.Gianluca Ingrosso, Eleonora Festa, Saverio Caini
|Feb 19, 2025
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719).Giulio Francolini, Niccolò Bertini, Vanessa Di Cataldo
Pageof 4
Frequent Collaborators
6 joint publications
Isacco Desideri
4 joint publications
Gabriele Simontacchi
4 joint publications
Gianluca Ingrosso
3 joint publications
Vanessa Di Cataldo
3 joint publications
Icro Meattini
3 joint publications
Andrea Lancia
2 joint publications
Michele Aquilano
2 joint publications
Pierluigi Bonomo
2 joint publications
Daniela Greto
2 joint publications
Alessio Bruni
